このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
EMVision Medical Devices マネジメント
マネジメント 基準チェック /34
現在、CEO に関する十分な情報がありません。
主要情報
Scott Kirkland
最高経営責任者
AU$469.4k
報酬総額
| CEO給与比率 | 54.9% |
| CEO在任期間 | less than a year |
| CEOの所有権 | 5.0% |
| 経営陣の平均在職期間 | 2.5yrs |
| 取締役会の平均在任期間 | 5.1yrs |
経営陣の近況
Recent updates
Is EMVision Medical Devices (ASX:EMV) A Risky Investment?
Nov 21
Here's Why We're Not At All Concerned With EMVision Medical Devices' (ASX:EMV) Cash Burn Situation
Apr 24EMVision Medical Devices Ltd's (ASX:EMV) CEO Compensation Is Looking A Bit Stretched At The Moment
Nov 09We're Not Very Worried About EMVision Medical Devices' (ASX:EMV) Cash Burn Rate
Oct 04Companies Like EMvision Medical Devices (ASX:EMV) Are In A Position To Invest In Growth
Jun 17We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Jan 07We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Oct 04We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Jun 08Here's Why We're Not Too Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Situation
Feb 22Investors Who Bought EMvision Medical Devices (ASX:EMV) Shares A Year Ago Are Now Up 319%
Dec 20
We Think EMvision Medical Devices (ASX:EMV) Can Afford To Drive Business Growth
Nov 24CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -AU$3m |
| Sep 30 2023 | n/a | n/a | -AU$4m |
| Jun 30 2023 | AU$469k | AU$258k | -AU$4m |
| Mar 31 2023 | n/a | n/a | -AU$4m |
| Dec 31 2022 | n/a | n/a | -AU$5m |
| Sep 30 2022 | n/a | n/a | -AU$5m |
| Jun 30 2022 | AU$270k | AU$245k | -AU$6m |
| Mar 31 2022 | n/a | n/a | -AU$7m |
| Dec 31 2021 | n/a | n/a | -AU$7m |
| Sep 30 2021 | n/a | n/a | -AU$8m |
| Jun 30 2021 | AU$262k | AU$240k | -AU$8m |
| Mar 31 2021 | n/a | n/a | -AU$7m |
| Dec 31 2020 | n/a | n/a | -AU$5m |
| Sep 30 2020 | n/a | n/a | -AU$4m |
| Jun 30 2020 | AU$224k | AU$205k | -AU$3m |
| Mar 31 2020 | n/a | n/a | -AU$3m |
| Dec 31 2019 | n/a | n/a | -AU$3m |
| Sep 30 2019 | n/a | n/a | -AU$3m |
| Jun 30 2019 | AU$213k | AU$150k | -AU$3m |
| Mar 31 2019 | n/a | n/a | -AU$3m |
| Dec 31 2018 | AU$45k | AU$41k | -AU$2m |
報酬と市場: Scottの 総報酬 ($USD 310.65K ) は、 Australian市場 ($USD 296.08K ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Scottの報酬は増加しましたが、会社は利益を上げていません。
CEO（最高経営責任者
Scott Kirkland
less than a year
在職期間
AU$469,419
報酬
Mr. Scott Kirkland has been an Executive Director of EMvision Medical Devices Limited since July 11, 2017 and serves as its Chief Executive Officer and Managing Director since July 01, 2023. Mr. Kirkland h...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO, MD & Executive Director | less than a year | AU$469.42k | 5.01% A$ 8.4m | |
| CFO & Company Secretary | 6.9yrs | データなし | 1.36% A$ 2.3m | |
| Chief Technology Officer | 1.5yrs | データなし | データなし | |
| Chairman of Clinical Advisory Board & Chief Scientific Officer | 3.6yrs | データなし | 1.22% A$ 2.1m | |
| Head of Design | 3.4yrs | データなし | データなし | |
| Head of Tech Development | no data | データなし | データなし | |
| Head of Regulatory Affairs | 1.3yrs | データなし | データなし |
2.5yrs
平均在職期間
経験豊富な経営陣: EMVの経営陣は 経験豊富 であると考えられます ( 2.4年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO, MD & Executive Director | 7yrs | AU$469.42k | 5.01% A$ 8.4m | |
| Chairman of Clinical Advisory Board & Chief Scientific Officer | 5.1yrs | データなし | 1.22% A$ 2.1m | |
| Ex-Officio Member | 2.3yrs | データなし | データなし | |
| Independent Non-Executive Director | 3.8yrs | AU$274.57k | 0.056% A$ 93.3k | |
| Non-Executive Chairman | 6.3yrs | AU$349.37k | 2.42% A$ 4.1m | |
| Non-Executive Director | 6.3yrs | AU$218.18k | 1% A$ 1.7m | |
| Independent Non-Executive Director | 6.1yrs | AU$218.18k | 0.70% A$ 1.2m | |
| Member of Clinical Advisory Board | 5.1yrs | データなし | データなし | |
| Member of Clinical Advisory Board | 5.1yrs | データなし | データなし | |
| Member of Clinical Advisory Board | 5.1yrs | データなし | データなし | |
| Member of Clinical Advisory Board | 5.1yrs | データなし | データなし | |
| Ex-Officio Member | 2.3yrs | データなし | データなし |
5.1yrs
平均在職期間
経験豊富なボード: EMVの 取締役会 は 経験豊富 であると考えられます ( 5年の平均在任期間)。